Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Biedermann

Showing results (151-160 of 201) with videos related to

Pageof 21
Sort By:
Journal of Gastroenterology|July 28, 2022
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patientsSebastian Bruno Ulrich Jordi, Brian Matthew Lang, Jacqueline Wyss, et al.
Journal of Crohn'S & Colitis|June 17, 2026
Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial resultsVipul Jairath, Fernando Magro, Marijana Protic, et al.
Plos One|October 26, 2018
Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled studySandra Y Wotzka, Markus Kreuzer, Lisa Maier, et al.
Therapeutic Advances in Gastroenterology|August 11, 2023
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort studyBrian M Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, et al.
Journal of Crohn'S & Colitis|November 29, 2017
Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel DiseaseStephan R Vavricka, Jose A Galván, Heather Dawson, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2018
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease CohortSébastien Godat, Nicolas Fournier, Ekaterina Safroneeva, et al.
International Archives of Allergy and Immunology|October 22, 2023
Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease OutcomeAlexis Heil, Tobias Kuehlewindt, Anne Godat, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 15, 2025
Circulating Food Allergen-Specific Antibodies, Beyond IgG4, Are Elevated in Eosinophilic EsophagitisManal Bel Imam, Sayuri Iwasaki, Sophieke Lems, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2016
The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivityThomas Greuter, Sandra Schmidlin, Jaqueline Lattmann, et al.
International Archives of Allergy and Immunology|September 20, 2021
Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic EsophagitisAlain M Schoepfer, Camilla Schürmann, Sven Trelle, et al.
Pageof 21

Showing results (151-160 of 201) with videos related to

Sort By:
Pageof 21
Journal of Gastroenterology|July 28, 2022
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patientsSebastian Bruno Ulrich Jordi, Brian Matthew Lang, Jacqueline Wyss, et al.
Journal of Crohn'S & Colitis|June 17, 2026
Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial resultsVipul Jairath, Fernando Magro, Marijana Protic, et al.
Plos One|October 26, 2018
Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled studySandra Y Wotzka, Markus Kreuzer, Lisa Maier, et al.
Therapeutic Advances in Gastroenterology|August 11, 2023
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort studyBrian M Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, et al.
Journal of Crohn'S & Colitis|November 29, 2017
Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel DiseaseStephan R Vavricka, Jose A Galván, Heather Dawson, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2018
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease CohortSébastien Godat, Nicolas Fournier, Ekaterina Safroneeva, et al.
International Archives of Allergy and Immunology|October 22, 2023
Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease OutcomeAlexis Heil, Tobias Kuehlewindt, Anne Godat, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 15, 2025
Circulating Food Allergen-Specific Antibodies, Beyond IgG4, Are Elevated in Eosinophilic EsophagitisManal Bel Imam, Sayuri Iwasaki, Sophieke Lems, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2016
The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivityThomas Greuter, Sandra Schmidlin, Jaqueline Lattmann, et al.
International Archives of Allergy and Immunology|September 20, 2021
Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic EsophagitisAlain M Schoepfer, Camilla Schürmann, Sven Trelle, et al.
Pageof 21